الاتحاد الأوروبي - الهولندية - EMA (European Medicines Agency)

recordati rare diseases - osilodrostat fosfaat - cushing-syndroom - corticosteroïden voor systemisch gebruik - isturisa is geïndiceerd voor de behandeling van endogene het syndroom van cushing bij volwassenen.

الاتحاد الأوروبي - الهولندية - EMA (European Medicines Agency)

ceva-phylaxia co. ltd. - live recombinant fowlpox virus expressing the membrane fusion protein and the encapsidation protein of avian infectious laryngotracheitis virus (rfp-lt) and avian encephalomyelitis virus, strain calnek 1143 (ae) - immunologicals for aves, live viral vaccines, domestic fowl - kip - for active immunisation of chickens of 8 to 13 weeks of age in order to reduce the skin lesions due to fowlpox, to reduce the clinical signs and tracheal lesions due to avian infectious laryngotracheitis and to prevent egg production losses due to avian encephalomyelitis.

بلجيكا - الهولندية - Ecolab

ecolab deutschland gmbh -

بلجيكا - الهولندية - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

bayer ag - olie dispersie (od) - foramsulfuron 22,5 g/l (2,33%) isoxadifen-ethyl (safener) 22,5 g/l (2,34%)

الاتحاد الأوروبي - الهولندية - EMA (European Medicines Agency)

ceva-phylaxia co. ltd. - recombinant fowlpox virus expressing the membrane fusion protein and the encapsidation protein of avian infectious laryngotracheitis virus, live - kip - for active immunisation of chickens from 8 weeks of age in order to reduce the skin lesions due to fowlpox and to reduce the clinical signs and tracheal lesions due to avian infectious laryngotracheitis.

هولندا - الهولندية - myHealthbox

bayer ag - suspensie concentraat - 1,0x10^9 cfu/g bacillus amyloliquefaciens (voorheen subtilis) qst 713

الاتحاد الأوروبي - الهولندية - EMA (European Medicines Agency)

laboratorios lesvi s.l. - dimethylfumaraat - multiple sclerose, relapsing-remitting - immunosuppressiva - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

هولندا - الهولندية - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

lisdexamfetaminemesilaat 60 mg/stuk samenstelling overeenkomend met ; lisdexamfetamine 34,7 mg/stuk ; samenstelling overeenkomend met dexamfetamine 17,8 mg/stuk - capsule, hard - ammonia (e 527) ; cellulose, microkristallijn (e 460(i)) ; croscarmellose natrium (e 468) ; gelatine (e 441) ; ijzeroxide zwart (e 172) ; indigokarmijn (e 132) ; kaliumhydroxide (e 525) ; magnesiumstearaat (e 470b) ; propyleenglycol (e 1520) ; schellak (e 904) ; titaandioxide (e 171) ; zwarte inkt, ammonia (e 527) ; cellulose, microkristallijn (e 460) ; croscarmellose natrium (e 468) ; gelatine (e 441) ; ijzeroxide zwart (e 172) ; indigokarmijn (e 132) ; kaliumhydroxide (e 525) ; magnesiumstearaat (e 470b) ; propyleenglycol (e 1520) ; schellak (e 904) ; titaandioxide (e 171) ; zwarte inkt

بلجيكا - الهولندية - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

laboratoires medgen - adapaleen 1 mg/g; waterig benzoylperoxide 34,01 mg/g - eq. benzoylperoxide 25 mg/g - gel - adapalene, combinations

الاتحاد الأوروبي - الهولندية - EMA (European Medicines Agency)

pfizer europe ma eeig - respiratory syncytial virus, subgroup a, stabilized prefusion f protein / respiratory syncytial virus, subgroup b, stabilized prefusion f protein - respiratoire syncytiële virusinfecties - vaccins - abrysvo is indicated for:passive protection against lower respiratory tract disease caused by respiratory syncytial virus (rsv) in infants from birth through 6 months of age following maternal immunisation during pregnancy. zie hoofdstuk 4. 2 en 5. active immunisation of individuals 60 years of age and older for the prevention of lower respiratory tract disease caused by rsv. het gebruik van dit vaccin moet gebeuren in overeenstemming met officiële aanbevelingen.